D. Vistica

发表

ASPS-1, A Novel Cell Line Manifesting Key Features of Alveolar Soft Part Sarcoma

R. Shoemaker, D. Schrump, M. Hollingshead, 2011, Journal of pediatric hematology/oncology.

Glutathione-conferred resistance to antineoplastics: approaches toward its reduction.

S. Somfai-Relle, D. Vistica, B. Vistica, 1984, Cancer treatment reviews.

Immunohistochemical Discrimination Between the ASPL-TFE3 Fusion Proteins of Alveolar Soft Part Sarcoma

R. Shoemaker, M. Raffeld, S. Kenney, 2008, Journal of pediatric hematology/oncology.

BMC Cancer BioMed Central Research article Gene expression profiling of alveolar soft-part sarcoma (ASPS)

R. Shoemaker, M. Raffeld, D. Schrump, 2009 .

Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier.

N. Greig, S. Rapoport, Q. Smith, 1992, Cancer research.

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

D. Vistica, K. Suzukake, B. Petro, 1982, Biochemical pharmacology.

Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.

S. Somfai-Relle, D. Vistica, B. Vistica, 1984, Biochemical pharmacology.

21 – ACQUIRED RESISTANCE OF TUMOR CELLS TO L-PHENYLALANINE MUSTARD: IMPLICATIONS FOR THE DESIGN OF A CLINICAL TRIAL INVOLVING GLUTATHIONE DEPLETION

D. Vistica, Shakeel Ahmad, 1989 .

Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

R. Ozols, T. Hamilton, R. Young, 1984, Cancer research.

γ‐glutamyl transpeptidase (γ‐GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents

D. Vistica, D. Vistica, Shakeel Ahmad, 1987 .

Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system.

M. Rabinovitz, D. Vistica, 1979, Biochemical and biophysical research communications.

The development of lead encephalopathy in the suckling rat: effects of lead on: I. Capillary basement membrane, II. Collagen metabolism

D. Vistica, 1975 .

Hepatic-mediated elevation and maintenance of metastatic tumor cell glutathione.

A. Mulberg, S. Ahmad, D. Vistica, 1986, Biochemical pharmacology.

Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.

M. Rabinovitz, J. N. Toal, D. Vistica, 1978, Biochemical pharmacology.

Microvascular effects of lead in the neonatal rat. I. Histochemical and light microscopic studies.

F. Ahrens, D. Vistica, 1977, Experimental and molecular pathology.

Microvascular effects of lead in the neonatal rat. II. An ultrastructural study.

F. Ahrens, D. Vistica, 1977, Experimental and molecular pathology.

The effects of lead upon collagen synthesis and proline hydroxylation in the Swiss mouse 3T6 fibroblast.

F. Ahrens, D. Vistica, W. R. Ellison, 1977, Archives of biochemistry and biophysics.

Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.

E. Sausville, C. Hose, H. Ciolino, 2004, Molecular cancer therapeutics.

Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.

R. Kramer, K. Greene, S. Ahmad, 1987, Cancer research.

Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds.

V. Marquez, J. Driscoll, D. Vistica, 1980, Biochemical pharmacology.

Steroid receptors and steroid response in cultured LI 210 murine leukemia cells

D. Salomon, D. Vistica, 1979, Molecular and Cellular Endocrinology.

Therapeutic Vulnerability of an In Vivo Model of Alveolar Soft Part Sarcoma (ASPS) to Antiangiogenic Therapy

R. Shoemaker, M. Raffeld, D. Schrump, 2009, Journal of pediatric hematology/oncology.

Cellular pharmacokinetics of the phenylalanine mustards.

D. Vistica, 1983, Pharmacology & therapeutics.

Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.

M. Rabinovitz, D. Vistica, A. Rabon, 1979, Research communications in chemical pathology and pharmacology.

Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content.

D. Vistica, B. Vistica, K. Suzukake, 1983, Biochemical pharmacology.

Bioinformatic Analysis of Patient-Derived ASPS Gene Expressions and ASPL-TFE3 Fusion Transcript Levels Identify Potential Therapeutic Targets

D. Covell, A. Wallqvist, S. Kenney, 2012, PloS one.

A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cells.

M. Rabinovitz, D. Vistica, B. Schuette, 1980, Cancer Letters.

Differential competition with cytotoxic agents: an approach to selectivity in cancer chemotherapy.

D. Vistica, Y. Uehara, M. Rabinowitz, 1979, Science.

Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids.

D. Vistica, B. Schuette, 1981, Molecular pharmacology.

Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport.

M. Rabinovitz, D. Vistica, A. Rabon, 1979, Cancer letters.

Amino acids affecting melphalan transport and cytotoxicity in cultured l1210 cells. Abstr.

M. Rabinovitz, D. Vistica, Toal Jn, 1977 .

Effect of L-α-amino-γ-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemia

M. Rabinovitz, D. Vistica, A. Rabon, 1979 .

Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.

M. Rabinovitz, J. N. Toal, D. Vistica, 1976, Cancer treatment reports.

Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.

M. Rabinovitz, J. N. Toal, D. Vistica, 1978, Molecular pharmacology.

gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.

S. Ahmad, D. Vistica, L. Okine, 1987, Journal of cellular physiology.

Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid.

D. V. Von Hoff, D. Vistica, B. Torain, 1981, Cancer treatment reports.

MEMBRANE MANIPULATION AND CANCER CHEMOTHERAPY

F. Schiffman, D. Vistica, 1977, The Lancet.

Abstract 3415: Therapeutic targeting of the ASPL-TFE3 gene fusion in ASPS-1, a novel cell line derived from metastatic alveolar soft part sarcoma (ASPS)

R. Shoemaker, D. Schrump, M. Hollingshead, 2010 .

Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier

N. Greig, S. Rapoport, Q. Smith, 2004, Cancer Chemotherapy and Pharmacology.

Selective cytotoxicity of a system L specific amino acid nitrogen mustard.

D. R. Haines, R. Fuller, V. Marquez, 1987, Journal of medicinal chemistry.

Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier

N. Greig, S. Rapoport, Q. Smith, 2004, Cancer Chemotherapy and Pharmacology.

Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells.

S. Ahmad, D. Vistica, L. Okine, 1987, The Journal of biological chemistry.

Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.

R. Fuller, S. Ahmad, D. Vistica, 1986, Federation proceedings.

Gene expression profiling of alveolar soft-part sarcoma (ASPS)

M. Raffeld, D. Schrump, D. Vistica, 2009, BMC Cancer.

These results contrast with those obtained with a sensitive host tissue. the bone marrow progenitor cells of the white cell series (CFU-C). in that a high-affinity leucine transport system corresponding to system I was not identified.

D. Vistica, 2016 .

Enhancement of melphalan therapy with glutaminase:asparaginase.

M. Rabinovitz, D. Vistica, A. Rabon, 1978, Research communications in chemical pathology and pharmacology.

Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells.

M. Rabinovitz, D. Vistica, A. Rabon, 1979, Biochemical pharmacology.